文献速递皮肤肿瘤

抗癫痫药物使用与皮肤癌风险:全国性病例对照研究

Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
PubMed 文献 · J Am Acad Dermatol · 2019-05-28

该研究在丹麦2004至2015年间嵌套病例对照,按1:10匹配无病对照,评估常见抗癫痫药物高累积使用(≥500限定日剂量)与基底细胞癌、鳞状细胞癌(SCC)及恶性黑色素瘤的关联。多数抗癫痫药与皮肤癌无关,但卡马西平和拉莫三嗪与SCC相关,卡马西平呈剂量反应关系,绝对风险低。

要点

  • 多数抗癫痫药未显示与皮肤癌风险增加相关。
  • 卡马西平高累积使用与SCC相关(OR 1.88,95%CI 1.42-2.49)。
  • 拉莫三嗪高累积使用与SCC相关(OR 1.57,95%CI 1.12-2.22)。

核心结论

  • 多数抗癫痫药物与皮肤癌无关,但卡马西平和拉莫三嗪与鳞状细胞癌相关。

研究设计与样本

  • 丹麦全国性嵌套病例对照研究,2004至2015年识别皮肤癌患者,按1:10匹配无病对照。
  • 比较高累积抗癫痫药使用(≥500限定日剂量)与非使用者的皮肤癌比值比(OR)。

主要发现

  • 卡马西平使用与SCC相关:OR 1.88(95%CI 1.42-2.49),且有剂量反应关系证据。
  • 拉莫三嗪使用与SCC相关:OR 1.57(95%CI 1.12-2.22)。
  • 估计绝对风险低:需6335人年高累积卡马西平暴露才额外发生1例SCC。

关键数值与推荐

  • 高累积暴露定义为≥500限定日剂量。
  • 卡马西平与SCC的OR为1.88(95%CI 1.42-2.49)。
  • 拉莫三嗪与SCC的OR为1.57(95%CI 1.12-2.22)。
  • 卡马西平每6335人年高累积暴露额外发生1例SCC。

临床怎么用

  • 多数抗癫痫药无需因皮肤癌风险改变临床决策。
  • 使用卡马西平或拉莫三嗪者应关注SCC风险,但绝对风险低。
  • 原文指出这些发现无直接临床意义,需在其他场景进一步验证。

局限性

  • 缺乏皮肤癌重要风险因素如日晒暴露的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several antiepileptic drugs are photosensitizing; however, it is not known whether this confers an increased risk of skin cancer. OBJECTIVE: To examine the association between common antiepileptic drugs and basal cell carcinoma, squamous cell carcinoma (SCC), and malignant melanoma. METHODS: We conducted a nested case-control study identifying skin cancer patients in Denmark from 2004 through 2015 matched 1:10 with disease-free controls. We estimated odds ratios (ORs) for skin cancer associated with high cumulative use of antiepileptic drugs (≥500 defined daily doses) compared with nonuse. RESULTS: Most antiepileptic drugs were not associated with skin cancer. SCC was associated with use of carbamazepine (OR, 1.88; 95% confidence interval, 1.42-2.49) and lamotrigine (OR, 1.57; 95% confidence interval, 1.12-2.22) with evidence of a dose-response relationship for carbamazepine. The estimated absolute risks were low; for example, 6335 person-years of high cumulative exposure to carbamazepine were required for 1 additional SCC to occur. LIMITATIONS: Data on important risk factors for skin cancer, such as sun exposure, were not available. CONCLUSIONS: Most antiepileptic drugs were not associated with skin cancer; however, carbamazepine and lamotrigine were associated with SCC. These findings need to be replicated and characterized further in other settings and have no direct clinical implications.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Kristensen KB, Pedersen SA, Schmidt SAJ, et al. Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study. J Am Acad Dermatol. 2019. PMID: 31150714. doi:10.1016/j.jaad.2019.05.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。